OVAPRINT

Live / Applied — Third extension granted (statement of use) (as of 04 Mar 2026)

What this means for you

Not registered yet, but its 26 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98242727
Mark type
Stylized text
Filed
26 Oct 2023
Published for opposition
16 Jul 2024
Attorney of record
Naira Simmons

Goods and services

  • Class 005 — Pharmaceuticals: Clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for testing biopsy and other tissue samples for use in disease detection, namely, ovarian cancer; clinical diagnostic testing kits comprised of medical diagnostic reagents, machine learning classifier/algorithms, and assays for ovarian cancer surveillance, namely, clinical detection reagents and clinical kits for measuring amounts of methylation levels in one or more target genomic regions of and other select biomarkers contacted with the reagent

Owner

Prosecution history

  • 05 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 04 Mar 2026 — SOU EXTENSION 3 GRANTED
  • 04 Mar 2026 — SOU EXTENSION 3 FILED
  • 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
  • 14 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 13 Aug 2025 — SOU EXTENSION 2 GRANTED
  • 13 Aug 2025 — SOU EXTENSION 2 FILED
  • 13 Aug 2025 — SOU TEAS EXTENSION RECEIVED
  • 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 04 Mar 2025 — SOU EXTENSION 1 GRANTED
  • 03 Mar 2025 — SOU EXTENSION 1 FILED
  • 03 Mar 2025 — SOU TEAS EXTENSION RECEIVED
  • 10 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 16 Jul 2024 — PUBLISHED FOR OPPOSITION

View this trademark record on Marksy